{"nct_id":"NCT01498484","title":"Therapeutic Effects of Epstein-Barr Virus Immune T-Lymphocytes Derived From a Normal HLA-Compatible Or Partially-Matched Third-Party Donor in the Treatment of EBV Lymphoproliferative Disorders and EBV-Associated Malignancies","status":"COMPLETED","status_verified_date":"2022-09","start_date":"2011-12","start_date_type":"ACTUAL","primary_completion_date":"2019-07","primary_completion_date_type":"ACTUAL","completion_date":"2019-07","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["ATRA"]}